Retatrutide has emerged as a new pharmaceutical in the fight against obesity. This revolutionary drug, classified as a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By activating https://safiyazpbi562621.wssblogs.com/36101105/tirzepatide-a-promising-new-treatment-for-obesity